MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-23-0073393
Kapynag Pharma Private Limited - pharma in Nashik, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.16 Lakh
▼ 96% YoY
Net loss · FY 2025
₹26.5 Lakh
Net margin -324.8%
EBITDA · FY 2025
-₹19.56 Lakh
EBITDA margin -239.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹60 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
15
Provident fund records
About Kapynag Pharma Private Limited
Data last updated:
Kapynag Pharma Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2017PTC299496. Its GSTIN is 27AAGCK7707B1ZO (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Gangadhar Ramchandra Kakulate and Lalit Dnyandeo Dhondge.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M/S Agri Search India Pvt. Ltd. Unit – 2 G. No. 211 At Pimpalnare Tal Dindori, Nashik, Maharashtra, India – 422202.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.16 Lakh, a decline of 96% compared to the previous year. For the same year it recorded a net loss of ₹26.5 Lakh (net margin -324.8%) and EBITDA of -₹19.56 Lakh (EBITDA margin -239.7%). Revenue has declined at a compounded annual rate (CAGR) of 69% over three years and 30% over five years.
The company has about 15 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Kapynag Pharma. As per MCA filings, the company has open charges of ₹60 Lakh on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Kapynag Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-23-0073393). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kapynag.com.
Company Details of Kapynag Pharma Private Limited
CIN U51909MH2017PTC299496
Registration Number 299496
Incorporation Date 08 September 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-23-0073393
Key People
Gangadhar Ramchandra Kakulate Director Lalit Dnyandeo Dhondge Director Ashwini Girish Dhondge Director Recognitions & Rankings of Kapynag Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressM/S Agri Search India Pvt. Ltd. Unit – 2 G. No. 211 At Pimpalnare Tal Dindori, Nashik, Maharashtra, India – 422202
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Kapynag Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Kapynag Pharma Private Limited
Kapynag Pharma operates one associated brand: Kapynag Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and third-party services in India. | kapynag.com |
Business Activity of Kapynag Pharma Private Limited
The main business activity of Kapynag Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kapynag Pharma Private Limited FY 2025 filings available
Kapynag Pharma Private Limited reported revenue of ₹8.16 Lakh (down 96% YoY) for FY 2025.
Revenue · FY 2025
₹8.16 Lakh ▼ 96%
Net loss · FY 2025
₹26.5 Lakh margin -324.8%
EBITDA · FY 2025
-₹19.56 Lakh margin -239.7%
Compounded Annual Growth Rate (CAGR) of Kapynag Pharma Private Limited
Revenue CAGR growth
1 year
▼ 96%
3 years · compounded
▼ 69%
5 years · compounded
▼ 30%
EBITDA CAGR growth
1 year
▼ 272%
3 years · compounded
▼ 49%
5 years · compounded
▼ 33%
Revenue has declined at a compounded annual rate (CAGR) of 30% over five years, including a 96% fall in the latest year. EBITDA fell 272% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kapynag Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹19.56 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹26.5 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kapynag Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -239.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -324.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kapynag Pharma are in the company report.
Premium access
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Kapynag Pharma Private Limited
Kapynag Pharma has 3 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gangadhar Ramchandra Kakulate | Director | 25 Jun 2022 | 4 Years 3 Months | Current |
| Lalit Dnyandeo Dhondge | Director | 21 Jan 2022 | 4 Years 9 Months | Current |
| Ashwini Girish Dhondge | Director | 05 Jan 2019 | 7 Years 9 Months | Current |
Peer Comparison of Kapynag Pharma Private Limited
Kapynag Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Letos Lifesciences Private Limited | ₹8.28 Lakh (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Hamara Remedies Private Limited | ₹8.24 Lakh (FY 2024) | •••• | •••• | -39.0% | •••• | Saharanpur, Uttar Pradesh, India |
| Cam Neuro Pharma Private Limited | ₹8.21 Lakh (FY 2024) | •••• | •••• | -84.0% | •••• | Cuttack Sadar, Odisha, India |
| Lusek Medicare Private Limited | ₹8.21 Lakh (FY 2025) | •••• | •••• | 932.0% | •••• | Mumbai, Maharashtra, India |
| Ebullient Pharmaceuticals Private Limited | ₹8.17 Lakh (FY 2025) | •••• | •••• | -25.0% | •••• | Satara, Maharashtra, India |
| Kapynag Pharma Private Limited this company | ₹8.16 Lakh (FY 2025) | •••• | •••• | -96.0% | •••• | Nashik, Maharashtra, India |
| Ellia Cytocare Private Limited | ₹8.12 Lakh (FY 2025) | •••• | •••• | -51.0% | •••• | Chauhan Patti, Delhi, India |
| Vijay Shree Chem Drugs Private Limited | ₹8.12 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Uttar Pradesh, India |
| PRK Pharmanlysts Private Limited | ₹8.07 Lakh (FY 2024) | •••• | •••• | 22.0% | •••• | Hyderabad, Telangana, India |
| Human Tissue Technology Private Limited | ₹8.06 Lakh (FY 2025) | •••• | •••• | 48.0% | •••• | Ahmedabad, Gujarat, India |
| Wockridge Global Healthcare Private Limited | ₹8.06 Lakh (FY 2025) | •••• | •••• | -85.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Kapynag Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Kapynag Pharma Private Limited
Kapynag Pharma Private Limited is audited by A V KOTHWADE AND ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A V KOTHWADE AND ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Kapynag Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kapynag Pharma Private Limited
Open charges
₹60 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Mar 2022 | Hdfc Bank Limited | ₹60 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Kapynag Pharma Private Limited
Kapynag Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending. Status as checked on 04 Oct 2026.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Akola, Maharashtra | Civil suit | Filed against the company by Stae of Maharashtra THR. Inspector Weight and Meserment Department, Akot | Pending |
Premium access
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Kapynag Pharma Private Limited
Kapynag Pharma Private Limited has a workforce of 15 employees as of Apr 01, 2024.
Employee count
15
Active EPFO establishments
1
Employee growth
-6.25%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kapynag Pharma Private Limited
Kapynag Pharma Private Limited has 17 board changes on record since 2017: 4 appointments and 13 cessations. The latest: Pankaj Subhash Pate ceased to be Director on 01 Aug 2022.
AGM
Kapynag Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kapynag Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Hdfc Bank Limited of Rs. 60.00 Lakh registered on 23 Mar 2022 with Charge ID 100559718 was modified on 08 Aug 2023.
Ceased
Pankaj Subhash Pate ceased to be Director.
Appointed
Gangadhar Ramchandra Kakulate was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 60.00 Lakh with Charge ID 100559718 was registered on 23 Mar 2022.
Appointed
Lalit Dnyandeo Dhondge was appointed as Director.
Ceased
Amit Sawata Hirve ceased to be Director.
Ceased
Bhavana Kunal Wagh ceased to be Director.
Ceased
Kapil Dilip Rege ceased to be Director.
Ceased
Pravin Suresh Yeole ceased to be Director.
Ceased
Pyarelal Madhukar Paradeshi ceased to be Director.
10 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Kapynag Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kapynag Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kapynag Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kapynag Pharma Private Limited
Kapynag Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCK7707B1ZO | Maharashtra | Active | 30 Jul 2018 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kapynag Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kapynag Pharma Private Limited
Kapynag Pharma is an active private limited company based in Nashik, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 September 2017 (9+ years old) and is registered under CIN U51909MH2017PTC299496.
Kapynag Pharma reported revenue of ₹8.16 Lakh for FY 2025 (down 96% YoY).
Kapynag Pharma has 3 current directors:
- Gangadhar Ramchandra Kakulate - Director
- Lalit Dnyandeo Dhondge - Director
- Ashwini Girish Dhondge - Director
Kapynag Pharma reported a net loss of ₹26.5 Lakh (net margin -324.8%) and EBITDA of -₹19.56 Lakh (EBITDA margin -239.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kapynag Pharma is -69% over three years and -30% over five years. In the latest year (FY 2025) revenue fell 96%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kapynag Pharma is 27AAGCK7707B1ZO, registered in Maharashtra.
The CIN (Corporate Identification Number) of Kapynag Pharma is U51909MH2017PTC299496. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kapynag Pharma has 1 court case on record: 1 filed against it. 1 is pending.
Kapynag Pharma was incorporated on 08 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Kapynag Pharma by revenue are Letos Lifesciences Private Limited, Hamara Remedies Private Limited, Cam Neuro Pharma Private Limited, Lusek Medicare Private Limited, Ebullient Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Pankaj Subhash Pate ceased to be Director on 01 Aug 2022. Gangadhar Ramchandra Kakulate was appointed as Director on 25 Jun 2022. Lalit Dnyandeo Dhondge was appointed as Director on 21 Jan 2022. Kapynag Pharma has 17 board changes on record in total.